Sebela is committed to improving patients’ lives by developing, marketing and selling differentiated branded prescription pharmaceuticals that bring meaningful value to patients affected by gastrointestinal, dermatological and women’s health diseases.

To fulfill its commitment to improving patient’s lives, Sebela is continuing to grow its US commercial infrastructure, marketed product portfolio and late stage development pipeline in its core therapeutic areas. Its growth strategy includes in-licensing and acquiring late-stage drug candidates and marketed products that utilize and enhance its existing development and commercial capabilities.